A phase 3 trial in pancreatic cancer, run by Case Comprehensive Cancer Center, now recruiting.
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy? is a phase 3, randomised interventional study registered as NCT05720338 by Case Comprehensive Cancer Center, with a registry enrolment figure of 234 participants, started 2023-04-13 and due to reach its primary completion in 2026-12-31. Interventions recorded: 19 French Blake Drain. Conditions listed: Cyst of Pancreas; Pancreatectomy; Pancreas Neoplasm. Primary outcome: Composite endpoint comparison; Composite endpoint comparison; Composite endpoint comparison. Pancreatic eligibility wording from the registry: "* Subjects must be undergoing a scheduled distal pancreatectomy (with or without concurrent splenectomy)". Sites: United States. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/